Literature DB >> 27285794

Bioavailability and bioconcentration potential of perfluoroalkyl-phosphinic and -phosphonic acids in zebrafish (Danio rerio): Comparison to perfluorocarboxylates and perfluorosulfonates.

Fangfang Chen1, Zhiyuan Gong2, Barry C Kelly3.   

Abstract

Currently, information regarding bioavailability and bioconcentration potential of perfluoroalkyl phosphinic acids (PFPiAs) in aquatic organisms does not exist. The main objective of the present study was to assess uptake and elimination kinetics of PFPiAs in zebrafish (Danio rerio) following aqueous exposure. The results showed that PFPiA exposure can result in very high steady-state bioconentration factors (BCFss), compared to perfluorocarboxylates and perfluorosulfonates.C6/C10 PFPiA exhibited the highest BCFss, ranging between 10(7) and 10(10), orders of magnitude higher than those for long-chain perfluorocarboxylates. Strong positive relationships were observed between BCFss versus the membrane-water distribution coefficient (Dmw) and the protein-water partition coefficient (Kpw) of the studied perfluoroalkyl substances. However, BCFss exhibited a substantial drop for the very hydrophobic PFPiAs (C8/C10 and C6/C12 PFPiAs). The reduced BCFss of these long-chain PFPiAs (perfluoroalkyl chain length=18; Dmw=10(9)) is likely the result of reduced bioavailability due to interaction with solute molecules/organic matter present in the water phase and/or reduced gill membrane permeability. While PFPiAs can be metabolized to perfluoroalkyl phosphonic acids, the metabolic transformation rate seems insufficient to counteract the high degree of uptake across gill membranes. These findings help to better understand exposure pathways and bioaccumulation behavior of these important perfluorinated acids in aquatic systems.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bioaccumulation; Bioconcentration factors; Kinetics; Perfluoroalkyl phosphinic acids; Perfluoroalkyl phosphonic acids; Zebrafish

Mesh:

Substances:

Year:  2016        PMID: 27285794     DOI: 10.1016/j.scitotenv.2016.05.215

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  6 in total

1.  Developmental exposures to perfluorooctanesulfonic acid (PFOS) impact embryonic nutrition, pancreatic morphology, and adiposity in the zebrafish, Danio rerio.

Authors:  Karilyn E Sant; Kate Annunziato; Sarah Conlin; Gregory Teicher; Phoebe Chen; Olivia Venezia; Gerald B Downes; Yeonhwa Park; Alicia R Timme-Laragy
Journal:  Environ Pollut       Date:  2021-02-04       Impact factor: 8.071

2.  Subtle morphometric, behavioral and gene expression effects in larval zebrafish exposed to PFHxA, PFHxS and 6:2 FTOH.

Authors:  Kate M Annunziato; Carrie E Jantzen; Melissa C Gronske; Keith R Cooper
Journal:  Aquat Toxicol       Date:  2019-01-14       Impact factor: 4.964

3.  Biological Cleavage of the C–P Bond in Perfluoroalkyl Phosphinic Acids in Male Sprague-Dawley Rats and the Formation of Persistent and Reactive Metabolites.

Authors:  Shira Joudan; Leo W Y Yeung; Scott A Mabury
Journal:  Environ Health Perspect       Date:  2017-11-03       Impact factor: 9.031

4.  A food web bioaccumulation model for the accumulation of per- and polyfluoroalkyl substances (PFAS) in fish: how important is renal elimination?

Authors:  Jennifer M Sun; Barry C Kelly; Frank A P C Gobas; Elsie M Sunderland
Journal:  Environ Sci Process Impacts       Date:  2022-08-17       Impact factor: 5.334

5.  Toxicokinetic Modeling of Per- and Polyfluoroalkyl Substance Concentrations within Developing Zebrafish (Danio rerio) Populations.

Authors:  Ross M Warner; Lisa M Sweeney; Brett A Hayhurst; Michael L Mayo
Journal:  Environ Sci Technol       Date:  2022-09-02       Impact factor: 11.357

6.  Invited Perspective: PFAS Bioconcentration and Biotransformation in Early Life Stage Zebrafish and Its Implications for Human Health Protection.

Authors:  Tamara Tal; Carolina Vogs
Journal:  Environ Health Perspect       Date:  2021-07-21       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.